BioWorld

July 12, 2002

Serono Enlists Marketing Muscle' Of Pfizer In $200M Rebif Alliance

Serono SA is teaming up with Pfizer Inc. to co-promote the multiple sclerosis drug Rebif in the United States, which will position Rebif directly against Biogen Inc.'s powerhouse drug Avonex. (BioWorld Today) Read More

MedImmune Working Feverishly' On Resolving FluMist Concerns

Human Equivalent Of Nematode Dog-1 Implicates Mutated Protein In BRCA1 Breast Cancer Tumors

BioCryst Trims Staff, Changes Focus To Earlier-Stage Programs

Other News To Note

Bioethics Council Votes 10-7 For Therapeutic Cloning Moratorium

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Feb. 9, 2025.

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026